Systematic review: The treatment of noncardiac chest pain with antidepressants

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 5, 2012, Pages 493-500

  Nguyen, T M T ^a   Eslick, G D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; PAROXETINE; PLACEBO; SERTRALINE; TRAZODONE; VENLAFAXINE;

ANOREXIA; ARTHRALGIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; CONSTIPATION; DELAYED EJACULATION; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION DISORDER; FATIGUE; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HUMAN; INSOMNIA; LIBIDO; MYALGIA; NAUSEA; NONCARDIAC CHEST PAIN; OUTCOME ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; QT INTERVAL; RESTLESSNESS; REVIEW; RHINITIS; RISK REDUCTION; SCORING SYSTEM; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SYSTEMATIC REVIEW; THORAX PAIN; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; GASTROESOPHAGEAL REFLUX; HUMANS; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 84856718848     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04978.x     Document Type: Review

References (17)

1. Kachintorn U,. How do we define non-cardiac chest pain? J Gastroenterol Hepatol 2005; 20 (Suppl.): S2-5. (Pubitemid 44933470)
2. Eslick GD, Jones MP, Talley NJ,. Non-cardiac chest pain: prevalence, risk factors, impact and consulting-a population-based study. Aliment Pharmacol Ther 2003; 17: 1115-24. (Pubitemid 36605748)
3. Fox M, Forgacs I,. Unexplained (non-cardiac) chest pain. Clin Med 2006; 6: 445-9. (Pubitemid 44690277)
4. Van HD, Fass R,. The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol 2005; 20 (Suppl.): S6-13. (Pubitemid 44933471)
5. Palsson OS,. Heart-focused anxiety as a mediating variable in the treatment of non-cardiac chest pain by cognitive-behavioural and psychopharmacological treatment by paroxetine (commentary). J Psychosom Res 2010; 69: 237-9.
6. Fass R, Dickman R,. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006; 18: 408-17. (Pubitemid 43742554)
7. Clouse RE, Lustman PJ, Eckert TC, et al,. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo controlled trial. Gastroenterology 1987; 92: 1027-36. (Pubitemid 17046322)
8. Cremonini F, Wise J, Moayyedi P, et al,. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a meta-analysis. Am J Gastroenterol 2005; 100: 1226-32. (Pubitemid 40904341)
9. Olden KW,. The psychological aspects of noncardiac chest pain. Gastroenterol Clin North Am 2004; 33: 61-7. (Pubitemid 38388265)
10. Schmulson MJ, Valdovinos MA,. Current and future treatment of chest pain of presumed esophageal origin. Gastroenterol Clin North Am 2004; 33: 93-105. (Pubitemid 38388267)
11. Lee H, Kim JH, Min BH, et al,. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterology. 2010; 105: 1504-12.
12. Cannon RO, Quyyumi AA, Mincemoyer R, et al,. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330: 1411-7. (Pubitemid 24139233)
13. Varia I, Logue E, O'Connor C, et al,. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367-72.
14. Spinhoven P, Van der Does AJW, Van Dijk E, et al,. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine. J Psychosom Res 2010; 69: 227-35.
15. Doraiswamy PM, Varia I, Hellegers C, et al,. A randomized controlled trial of paroxetine for noncardiac chest pain. Psychopharmacol Bull 2006; 39: 15-24.
16. Rao SSC,. Diagnosis and management of esophageal chest pain. Gastroenterol Hepatol 2011; 7: 50-2.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred Reporting Items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-9.